Fundz

Swansea Biotech Startup Raises £1.5M For Ai Bowel Cancer Blood Test

PRIVATEMar 09, 2023

Amount Raised

£1.5 Million

Round Type

Seed

BiotechnologyHealth Care

Description

Biotech startup CanSense, which has developed a blood test to detect bowel cancer that uses laser light and artificial intelligence (AI), has raised £1.5m in funding.

Quick answer

CanSense raised £1.5 Million in a Seed round, dated March 9, 2023.

How much did CanSense raise?
CanSense raised £1.5 Million in a Seed round on March 9, 2023.
What does CanSense do?
At CanSense we utilise cutting-edge data analytics and machine learning to maximise the performance of our blood test aimed at triaging patients at high risk of cancer.
Who are the decision-makers at CanSense?
Fundz holds 1 contact at CanSense. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as CanSense that raised within 45 days of this round, from Fundz verified event records.

  • Trellis Bioscience raised $1.4M on April 20, 2023.
  • Lifeist Wellness raised an undisclosed amount (Debt Financing) on April 20, 2023.
  • Phio Pharmaceuticals raised $4M (Seed) on April 20, 2023.
  • MedShift raised $108M (Funding Round) on April 20, 2023.
  • Hasten Biopharmaceutic Ltd raised $315M (Funding Round) on April 20, 2023.
  • Legend Biotech raised $200M on April 19, 2023.

Who to call at CanSense, and when

A new round usually means CanSense is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CanSense raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CanSense, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CanSense. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CanSense

About

At CanSense we utilise cutting-edge data analytics and machine learning to maximise the performance of our blood test aimed at triaging patients at high risk of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CanSense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for CanSense's next move

See what Strategic adds

CanSense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.